Analystreport

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) had its price target lowered by analysts at Wells Fargo & Co from $189.00 to $162.00. They now have an "overweight" rating on the stock.

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com